share_log

Virpax Pharmaceuticals | ARS: Annual Report to Security Holders

Virpax Pharmaceuticals | ARS: Annual Report to Security Holders

Virpax製藥 | ARS：年度報告
美股SEC公告 ·  06/13 05:13
牛牛AI助理已提取核心訊息
Virpax Pharmaceuticals has made an announcement regarding the launch of Epoladerm™, a new non-opioid pain management product. Epoladerm™ is presented as a diclofenac epolamine spray film, specifically formulated to treat acute pain associated with minor injuries such as strains, sprains, and contusions. The company has underscored the significance of Epoladerm™, particularly its non-opioid characteristic and user-friendly spray film application, which aligns with Virpax's dedication to providing alternative pain management options in the midst of the ongoing opioid crisis.
Virpax Pharmaceuticals has made an announcement regarding the launch of Epoladerm™, a new non-opioid pain management product. Epoladerm™ is presented as a diclofenac epolamine spray film, specifically formulated to treat acute pain associated with minor injuries such as strains, sprains, and contusions. The company has underscored the significance of Epoladerm™, particularly its non-opioid characteristic and user-friendly spray film application, which aligns with Virpax's dedication to providing alternative pain management options in the midst of the ongoing opioid crisis.
Virpax藥品公司宣佈推出Epoladerm™，一款新型非阿片類疼痛管理產品。Epoladerm™是一種地氯芬酸表沙漠膠囊噴霧膜，專爲治療輕微創傷引起的急性疼痛，如扭傷、拉傷和挫傷等而特別配製。該公司強調了Epoladerm™的重要性，特別是其非阿片類的特點和用戶友好的噴霧膜應用，與Virpax致力於在持續發生的阿片類藥物危機中提供替代疼痛管理選項的承諾相一致。
Virpax藥品公司宣佈推出Epoladerm™，一款新型非阿片類疼痛管理產品。Epoladerm™是一種地氯芬酸表沙漠膠囊噴霧膜，專爲治療輕微創傷引起的急性疼痛，如扭傷、拉傷和挫傷等而特別配製。該公司強調了Epoladerm™的重要性，特別是其非阿片類的特點和用戶友好的噴霧膜應用，與Virpax致力於在持續發生的阿片類藥物危機中提供替代疼痛管理選項的承諾相一致。
有用
沒用

該公告為獨立文件：

獨立文件1

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。